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Abstract
Several methodologies for the preparation of polyethylene glycol-grafted immunoliposomes have been developed by
attaching antibodies to the terminus of the polymer. Unilamellar liposomes were prepared containing a combination of a
functionalized polyethylene glycol(3400) and an inert polyethylene glycol(2000) phosphatidylethanolamine derivate up to
5 mol%. The greater length of the functionalized polyethylene glycol derivate did not alter the liposomal sterical stability or
the remote loading of doxorubicin. Anti-CD34 immunoliposomes were prepared by the reaction of maleimide-derivatized
My10 antibody with generated thiol groups at the periphery of the liposomes and efficiencies of nearly 100% were obtained.
The greater accessibility of the reactive group makes this strategy more efficient than others described. The
immunoliposomes prepared bound specifically to CD34+ cells. ß 1999 Elsevier Science B.V. All rights reserved.
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The recent development of reticuloendothelial sys-
tem (RES)-evading sterically stabilized liposomes
(SL) prepared by coating the liposome surface with
amphipatic polyethylene glycols (polyethylene glycol-
phosphatidylethanolamine, PEG-PE, 4^8 mol% of
the total lipid) holds a great promise for the liposo-
mal drug delivery [1]. PEG-grafted liposomes exhibit
dose-independent long circulating blood lifetimes, a
reduced interaction with and uptake by liver and
spleen macrophages and an enhanced accumulation
in tumors [2^5]. PEG chains are believed to prevent
or diminish the adsorption of opsonizing proteins,
which direct the liposomes to macrophages [6,7], as
a result of their conformational £exibility and their
water-binding ability [5,8].
Conventional liposomes coated with monoclonal
antibody (mAb) are quickly removed from the circu-
lations by the RES and the immunotargeting e⁄-
ciency depends on the mAb density on the surface,
which limits their use for the systemic drug delivery
system [5]. In the last few years, a number of advan-
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ces have been reported in methodologies for the
preparation of sterically stabilized immunoliposomes
(SIL) [9^11]. Attachment of proteins to the distal end
of the PEG-terminus minimizes the interference of
the polymer chains observed in antibody-antigen in-
teractions and in conjugation reactions when mAbs
are coupled to polar head groups of phospholipid
components [9,12]. Various methodologies have
been studied for coupling ligands to functionalized
PEG-PE derivates incorporated into liposomes [9^
11], which retained long survival times in the circu-
lation and target recognition in vivo [13,14]. The pa-
rameters examined included the binding e⁄ciency,
antibody surface density, maintenance of liposomal
steric stabilization, speci¢c binding to target cells and
drug remote loading e⁄ciency.
In this report, we explore a new strategy to pre-
pare SIL with a combination of both short methoxy-
PEG(2000)-PE (mPEG-PE) and long functionalized
PEG(3400)-PE. The mPEG chains attached to the
liposome make these liposomes sterically stabilized.
Coupling the mAb at the functionalized PEG-termi-
nus on the same liposome may be to minimize inter-
ference of the polymers chains in conjugation reac-
tions and in antibody-antigen interactions. We have
used the coupling method developed by Allen et al.,
who used the PDP-PEG-PE derivate to attach the
mAb to the liposomes via a thioether bond [10].
SILs directed speci¢cally against CD34+ cells were
prepared using the My10 mAb [15]. My10-SILs were
characterized and evaluated for their in vitro binding
capacity to KG-1a cells, a human acute myelogenous
leukemia cell line expressing the human CD34 anti-
gen. The e¡ect of experimental variables on the SIL
preparation and on the SIL-cell interactions was
studied. To the best of our knowledge, this is the
¢rst study examining the use of PEG-PE derivates
of di¡erent chain length to prepare SIL.
Egg phosphatidylcholine (PC), hydrogenated soy
phosphatidylcholine (HPC), transphosphatidylated
egg phosphatidylethanolamine (PE) and mPEG-PE
were obtained from Avanti Polar Lipids. Cholesterol
(Chol), N-succinimidyl-3-(2-pyridyldithio)-propio-
nate (SPDP), succinimidyl-4-(p-maleimidophenyl)bu-
tyrate (SMPB) and dithiothreitol (DTT) were from
Sigma Chemical. t-Boc-NH-PEG(3400)-CO2-NHS
was from Shearwater Polymers. Doxorubicin (Dox)
was obtained from Pharmacia Upjo«rn and 5(6)-car-
boxy£uorescein (CF) from Eastman-Kodak. TLC on
silica gel 60G (Merck) (Cl3CH/CH3OH 80:18:2) was
visualized with iodine vapor, ninhydrin and phos-
pholipid phosphorus spray reagents.
The anti-My10 clone and cell lines were obtained
from the American Type Culture Collection. A
mouse IgG1, an isotype non-speci¢c Ab, was from
Becton-Dickinson. KG-1a, CHO and Jurkat cells
were grown as a suspension culture in RPMI 1640
medium and J774 cells were maintained in a mono-
layer culture in Dulbecco’s modi¢ed Eagle’s medium.
For both cell lines, culture media were supplemented
with 10% (v/v) fetal bovine serum, 2 mM L-gluta-
mine, 1 mM sodium pyruvate, 100 U penicillin and
100 Wg/ml streptomycin (Biological Industries). Cells
were maintained at 37‡C in a humidi¢ed atmosphere
containing 5% CO2.
We have synthesized a PE derivate of PEG(3400)
with terminal pyridyldithiopropionate (PDP) groups
(PDP-PEG-PE), as proposed by Allen et al. [10]. PE
(15.3 mg) was added to a solution of t-Boc-NH-
PEG(3400)-CO2-NHS (70 mg) dissolved in CHCl3
(0.5 ml), followed by TEA (16 Wl). The solution
was stirred for 2 h at room temperature. The solvent
was evaporated and replaced with acetonitrile and
the reaction mixture kept at 4‡C overnight. Under
these conditions, the excess of PE was precipitated
and was eliminated by centrifugation. The purity of
the product obtained was con¢rmed by TLC, obtain-
ing a single negative ninhydrin and phosphate posi-
tive spot. To obtain the NH2-PEG-PE, the t-Boc
group was quantitatively eliminated by incubation,
for 20 min at room temperature, with TFA (40% v/
v). Full deprotection of the primary amino group
was con¢rmed by TLC and visualized with ninhydrin
spray reagent. Finally, NH2-PEG-PE (60 mg), SPDP
(5.8 mg) and 13 Wl of TEA dissolved in CHCl3
(0.5 ml) were reacted at room temperature for 5 h.
The ¢nal product was crystallized in ether and ob-
tained with a weight yield of 70%. The molar ratio
PDP groups/phospholipid was higher than 0.9. PDP
groups were determined by the release of 2-thiopyr-
idinone upon the addition of an excess DTT [16] and
phospholipid was measured by a phosphorus assay
[17].
Liposomes composed of PC/Chol 2/1 and 5 mol%
of PEG derivates were prepared by extrusion tech-
niques, through polycarbonate ¢lters with a 0.1 Wm
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pore size, as described elsewhere [15]. The vesicle size
was characterized by dynamic laser light scattering
using a PCS41 optic unit (Malvern Autosizer IIC).
The system reports a polydispersity index as a meas-
ure of the particle size distribution. The stability of
liposomes was determined by measuring the release
of an entrapped dye, carboxy£uorescein (CF), in
PBS bu¡er [18]. Dox loading was carried out by
the ammonium sulfate gradient method proposed
by Bolotin et al. [19].
The steric stabilization of the prepared liposomes
was demonstrated by the following experiments.
Firstly, the presence of a steric barrier in the lipo-
some surface was demonstrated by the agglutination
assay [3,18]. Secondly, the amount of serum protein
adsorbed to liposomes of di¡erent compositions was
determined as described previously [18]. Thirdly, the
stability of liposomes in the presence of serum was
analyzed by measuring the leakage of entrapped CF
from the liposomes in the presence of 10% of human
serum [18]. Finally, we determined the binding to
and endocytosis of liposomes to a murine macro-
phage-like cell line, J774 [20]. Brie£y, cells were
plated at the density of 3U105 cells/9 cm2 plastic
culture dishes, 24 h before the experiments were car-
ried out. Liposomes containing 30 mM pyranine
(HPTS) were prepared as described above and incu-
bated with supplemented culture medium for 10 min
at 37‡C before addition to the cells. Cells were incu-
bated with the liposomes to a lipid concentration of
100 WM for di¡erent times. The non-associated lipo-
somes in solution were washed away at the end of
the incubation by rinsing three times with cold PBS.
Cells were dislodged by treatment with PBS bu¡er
containing 3 mM EDTA and after this, the associ-
ated £uorescence was measured immediately at Vex of
460 or 413 nm with a Vem of 510 nm.
In order to prepare the immunoliposomes, a sol-
ution of My10 mAb (1 mg/ml) in PBS (pH = 7.4) was
left to react for 2 h at room temperature with SMPB
(1 mg/ml in dimethylformamide) in an SMPB/protein
molar ratio of 20. The excess of SMPB was removed
by a Sephadex G-50 spin column equilibrated with
PBS at pH = 6.7. Simultaneously, a solution of lipo-
somes containing PDP-PEG-PE was reduced by in-
cubation with 50 mM DTT for 30 min at room tem-
perature. DTT was removed and the thiolated
liposomes were quickly mixed with the MPB mAb
and left at room temperature overnight. Next, the
liposome suspension was incubated with iodoacet-
amide (0.2 mM) for 2 h at room temperature in order
to block the free thiols remaining on the liposome
surface. Free mAb and the excess of iodoacetamide
were removed by chromatography on Sepharose 4B
[15]. The amount of mAb coupled to liposome was
calculated £uorimetrically, using FITC-My10, as de-
scribed previously [15].
The cell-binding assay was performed by direct
immuno£uorescence with My10-SIL entrapping CF
[15]. Exponentially growing cells (106 cells/ml) were
incubated with SIL for 30 min at 4‡C. The analysis
was performed in an EPICS Elite £ow cytometer
(IZASA-Coulter, Spain) using the 488 nm line of
an argon ion laser as the excitation source. All £uo-
rescence measurements were collected as a logarith-
mic signal. Sample acquisition was stopped when the
90LS-£uorescence histogram 10 000 gated events
were achieved.
A SL of 100 nm diameter can be achieved by in-
corporation of 5 mol% of mPEG-PE [9,10]. In order
to couple mAb at the terminal PEG chains, we in-
corporated in the lipid composition up to 2 mol% of
the PDP-PEG-PE derivate. Their complete incorpo-
ration was shown by the 100% release of 2-thiopyr-
idinone from liposomes following reduction of PDP
groups with DTT as determined spectrophotometri-
cally [16]. The substitution of mPEG-PE by PDP-
PEG-PE did not alter their stability. The liposomes
were stable at 37‡C with a CF leakage below 5% in
3 h in PBS. They had an average size of 125 þ 5 nm
and were stable for 2 months at 4‡C without changes
on their physicochemical parameters (data not
shown). Dox could be loaded e⁄ciently (s 92%) in
the basis of the Dox/lipid ratio obtained after remov-
ing the non-encapsulated drug (Table 1). Similar re-
sults had been obtained with PEG chains of the same
length [10]. The liposomal sterically stabilization was
not altered by the replacement of mPEG-PE by
PDP-PEG-PE. The agglutination assay shows that
the presence of a hydrophilic barrier at the liposome
surface inhibits avidin-biotin interactions (data not
shown) [3]. Moreover, the leakage of CF entrapped
in PEG liposomes in the presence of serum was
5-fold less than in conventional liposomes (data not
shown), consistent with the lower amount of serum
protein bound as a result of the hydrophilic barrier
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(Table 1). These results are consistent with others
published elsewhere [21,22].
The interaction with the macrophagic cell line J774
was also analyzed, since a low binding or uptake of
liposomes with macrophage cells in vitro corresponds
to a long time in vivo [23,24]. We entrapped in lip-
osomes HPTS a £uorescence marker allowing the
discrimination between the general uptake and the
part of liposomes internalized into the low pH com-
partment [20]. Binding at 4‡C, total uptake and the
internalization at 37‡C were lower for PEG lipo-
somes than for plain liposomes, even if they had a
combination of mPEG(2000) and PEG(3400) (Table
1). Sterical stabilization reduced the general uptake
of liposomes in vitro by more than 8-fold and the
internalization by about 6-fold in the conditions
tested (6 h at 37‡C), which is consistent with previous
results [23].
SILs were prepared by coupling of maleimide ac-
tivated mAb to the thiolated liposomes [10]. As dem-
onstrated previously [10,12,15], the amount of mAb
bound per vesicle depends on the number of reactive
groups on the liposome surface and the PDP/mAb
molar ratio in the incubation mixture. We tested var-
ious conditions, adjusting the PDP/mAb molar ratio
up to 30 and the mol% of PDP-PEG-PE incorpo-
rated in the lipid composition from 0.5 to 2. The
amount of antibody bound to liposome increased
as the PDP/mAb ratio decreased and with the in-
crease in PDP-PEG-PE percentage. On the other
Table 1
Serum protein adsoption, macrophage uptake and Dox loading of liposomes containing PDP-PEG-PE
Lipid Composition Serum protein bindinga
(mg protein/mmol lipid)








PC/Chol 2/1 628 þ 110 2.30 þ 1.61 4.32 þ 0.91 50 s 92
PC/Chol/mPEG-PE 12/6/1 185 þ 20 0.18 þ 0.16 0.51 þ 0.32 8 s 92
PC/Chol/mPEG-PE/PDP-
PEG-PE 12/6/0.6/0.4
190 þ 13 0.18 þ 0.15 0.34 þ 0.11 8 s 92
aBinding of serum proteins to liposomes was determinated by incubation of liposomes with human serum for 1 h at 37‡C. Unbound
proteins were removed by a Ficoll gradient. Protein was determined by the BCA method.
bBinding of liposomes to the macrophagic cell line J774 was measured by incubation of HPTS liposomes with cells for 30 min at 4‡C.
After removing unbound liposomes, the associated cell £uorescence was mesured £uorimetrically at Vex = 413 nm and Vem = 510 nm.
cTotal uptake and endocytosis determinations were done by incubation of HPTS liposomes with cells for 6 h at 37‡C. The amount of
liposomes taken up was determinated £uorimetrically at Vex = 413 nm and Vem = 510 nm. The ratio between excitation at 460 and 413
nm wavelength (460/413) was calculated and the percentage of endocytosed liposomes was estimated according to the method pro-
posed by Daleke et al. [20].
dTo the doxorubicin loading method, hydrogenated phosphatidylcholine was used instead of egg phosphatidylcholine.
Table 2
Coupling e⁄ciency and mAb density in liposomes containing PDP-PEG-PE
mol% PDP-PEG-PE PDP/mAb molar ratio mAb density (mAb/liposome) Coupling e⁄ciency (%)
2 10 286 þ 10 98 þ 3
2 20 155 þ 12 100 þ 2
2 30 92 þ 6 96 þ 3
1 30 60 þ 6 92 þ 5
0.5 30 23 þ 3 89 þ 3
0a 0 2 þ 1 1 þ 1
Liposomes were composed of a PC/Chol 2/1 molar ratio and contained 5 mol% total PEG derivates, consisting of a combination of
mPEG(2000)-PE and PDP-PEG(3400)-PE as indicated. The coupling procedure is described in detail in the text. The coupling e⁄-
ciency is expressed as the % of initial mAb attached to the liposomes.
aCalculated using the largest amount of mAb added.
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hand, the coupling e⁄ciency, which was independent
of the PDP-PEG-PE percentage, increased when the
PDP/mAb ratio increased, showing a saturation for
ratios above 10 (Table 2). These results are in ac-
cordance with those proposed by Allen et al. [10].
However, we obtained e⁄ciencies near to 100%
with PDP/mAb molar ratios s 10, which were higher
than others described elsewhere when PEG derivates
of the same length were used [10]. In the absence of
PDP-PEG-PE, very low amounts of mAb were asso-
ciated with the liposomes (6 2 mAb/vesicle), possibly
through passive adsorption. One can estimate that,
theoretically, up to 310 mAb can be bound to a 125
nm diameter liposome based on the assumption pre-
viously presented that the e¡ective diameter of an
IgG (150 000 Da) molecule is 142 Aî [10]. The max-
imum number of mAb bound to liposome was
achieved when we used a PDP/mAb molar ratio of
10 and liposomes that contain 2 mol% of PDP-PEG-
PE. In these conditions, approximately 286 mAb
bound to each vesicle, calculated in the basis of the
£uorescence associated with liposomes [15], which
coat 90% of the liposome surface. The high e⁄ciency
obtained entails a saving of mAb which production
tends to be an expensive process.
The immunoreactivity of SIL to CD34+ KG-1a
cells was demonstrated by £ow cytometry using CF
entrapped in liposomes as £uorescence marker. Incu-
bations were performed at 4‡C in order to inhibit
uptake processes and, as control, cells were incu-
bated with bare CF-SL. As can be seen in Fig. 1A,
the attachment of the My10 mAb to SL resulted in
an increased binding to KG-1a cells. The interaction
was also con¢rmed by confocal microscopy (data not
shown). The SILs were present only on the cell sur-
face, this was con¢rmed by examination of optical
cross-sections through the middle of the cells. Sub-
sequent incubation with 50 mM of DTT, 30 min at
4‡C, did not decrease the cell labelling, which sug-
gests a stable linkage between the mAb and the lip-
osome. To con¢rm that the cell-binding occurred
through speci¢c recognition of antibodies, SIL and
SL were incubated with di¡erent CD343 cell lines,
such as CHO or Jurkat (Fig. 1B). The SIL showed a
Fig. 1. (A) Cyto£uorimetric determination of CF-SIL (23 mAb/liposome)-binding to KG-1a cells (solid line) and speci¢c inhibition of
binding by free My10 and non-relevant IgGl Ab (dotted line). SILs (200 WM total lipid) were incubated with cells (106 cell/ml), 30
min at 4‡C and rinsed twice with PBA. An aliquot of Kg-1a cells was pre-incubated with free My10 or IgGl mAb (5 Wg), 30 min at
4‡C, washed in PBA to eliminate unbound antibody and incubated with 200 WM of SIL. Non-speci¢c £uorescence-binding was meas-
ured by incubating cells with CF-SL. The X-axis represents the logarithm of the green £uorescence signal and the Y-axis represents
the cell count. (B) Speci¢city of the SIL binding to CD34+ cells. Binding of CF-SIL or CF-SL to CD343 cells : CHO (dashed) and
Jurkat (open), and to CD34+ cells : KG-1a (¢lled). Liposomes (200 WM) with PDP (PDP-SL), methoxy (mPEG-SL) or acetamide
(AA-SL) groups at the liposome surface were incubated with cells (106 cell/ml), 30 min at 4‡C. In the same conditions, SIL (23 mAb/
vesicle) containing acetamide super¢cial groups (AA-SIL) were incubated with cells. Fluorescence associated to cells was measured by
£ow cytometry and represented as mean £uorescence intensity (MFI). Cells were used as negative control.
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non-speci¢c binding to CD343 cells similar to SL
(Fig. 1B). The quenching of excess active thiol
groups following the conjugation reaction seems to
be important in achieving a good selectivity of the
targeted liposome, since they could promote back-
ground binding to the cells lacking the target antigen
possibly due to non-speci¢c covalent attachment to
cell surface molecules (thiol exchange) [10,12]. For
this reason, the free thiol groups present on the lip-
osome surface were quenched by incubation with io-
doacetamide. The acetamide group did not a¡ect lip-
osome-cell binding, since the same non-speci¢c
binding was observed when a PDP group or an inert
methoxy group was present on the liposome surface.
Furthermore, an immuno-speci¢c interaction be-
tween SIL and KG-1a cells was demonstrated by
the partial inhibition of binding by free My10 mAb
but not by an isotype-matched non-speci¢c Ab
(mouse IgG1) (Fig. 1A). These results are in accord-
ance with others [15] and, moreover, ruled out the
possibility that the binding could be Fc-dependent,
since KG-1a cells are FcR+ [25].
The amount of SIL bound to speci¢c cells can be
increased by modifying parameters such as the anti-
body density at the liposome surface and the liposo-
mal lipid concentration in the incubation mixture, as
it has been demonstrated previously [9,10,12,15].
Binding to KG-1a cells incubated with di¡erent
amounts of SIL showed a dose-dependent manner
having a tendency to saturation (Fig. 2A). The de-
gree of SIL-binding is also dependent on the number
of mAb molecules present on the liposome surface
(Fig. 2B). We found that an increase in the mAb
density raises the binding e⁄ciency, even though it
shows saturation behavior.
In conclusion, we have prepared SIL directed
against CD34 antigen expressing cells with a thio-
ether linkage between the mAb and the vesicle, which
is stable in vivo. The use of a functionalized PEG
derivate longer than a non-functionalized PEG deri-
vate allows us to keep the liposomal steric stabiliza-
tion and to obtain SIL with a wide range of achiev-
able mAb densities at a high e⁄ciency of coupling.
These immunoliposomes show an e⁄cient drug re-
mote loading of Dox and e¡ective binding to target
cells in vitro. It is necessary to take into account that
the linking of mAb to the distal ends of longer PEG
chains could increase the immunogenic properties of
SIL, as previously reported [11], related to a major
exposure of the constant Fc region of mAb. Since the
immunogenicity of SIL in£uences their longevity in
the blood circulation and their ability to reach target
sites, another strategie that includes the use of a mi-
nor immunogenic device like mAb fragments [11,14]
or non-antibody ligands [26] could be used. Further
studies will attempt to analyze the potential of My10
SIL as drug delivery system to CD34+ cells in vivo.
Fig. 2. (A) The e¡ect of the lipid concentration on the degree
of immunoliposomes binding to KG-1a cells. CF-SILs (23
mAb/vesicle) were incubated 30 min at 4‡C with cells (106 cells/
ml). (B) The e¡ect of the antibody density on the immunolipo-
some-binding. Immunoliposomes containing di¡erent amounts
of mAb/vesicle (200 WM) were incubated with KG-1a cells (106
cells/ml) during 30 min at 4‡C. Samples were analyzed by £ow
cytometry as described previously using bare CF-SL as negative
control.
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